Vesigen Therapeutics is a biotechnology company advancing groundbreaking therapies directed to intracellular targets using a fusogenic extracellular vesicle delivery technology. Our patented technology, called ARMMs (ARRDC1 Mediated Microvesicles), is expanding the universe of druggable targets by enabling the delivery of a wide range of payloads, including RNAs (mRNA, shRNA, ribozymes), proteins (signaling proteins, enzymes, antibody fragments), and gene-editing complexes (Cas9/gRNA) directly into the cytoplasm of target cells. The team is committed to leveraging ARMMs technology to develop transformative medicines and address currently unmet medical needs.

Biotechnology

Vesigen Therapeutics

Paulash Mohsen

Qin Yu

Yashodhan Chinchore

Lorien Moore

Qiyu W.

Gang (Gary) Hao

Joseph Nabhan

The Leadership Team at Vesigen Therapeutics is responsible for setting the strategic direction and vision of the company, driving innovation in biotechnology, and ensuring alignment across all teams. Comprised of key executives, including the CEO and CSO, this team focuses on advancing the development of ARMMs technology, fostering partnerships, securing funding, and guiding the overall mission to deliver transformative therapies that address unmet medical needs.

Leadership Team

Scientific and Research Team

Board Team

Business Operations and Development

Leadership Team

About

Team members

Other teams at Vesigen Therapeutics

Scientific and Research Team

Board Team

Business Operations and Development